Alkriz
Alkriz is Crizotinib, a targeted ALK/ROS1/MET tyrosine kinase inhibitor. It is indicated for ALK-positive or ROS1-positive NSCLC and works by blocking abnormal kinase signaling that drives malignant cell growth.
Features
| Product Name | Alkriz |
| Generic Name | Crizotinib |
| Formulation | Capsule |
| Available Pack Size | 7X4's |
| Available Strength | 250MG |